MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS

Journal of the Neurological Sciences

Volumn 294, Issue 1-2, 2010, Pages 51-56

  Fang, Lubin ^a   Teuchert, Marko ^a   Huber Abel, Friederike ^a   Schattauer, Dagmar ^a   Hendrich, Corinna ^a   Dorst, Johannes ^a   Zettlmeissel, Heinz ^a   Wlaschek, Meinhard ^a   Scharffetter Kochanek, Karin ^a   Kapfer, Tamara ^a   Tumani, Hayrettin ^a   Ludolph, Albert C ^a   Brettschneider, Johannes ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Inflammatory cytokines; Matrix metalloproteinases; Oxidative stress; Skin

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ELECTROCHEMICAL DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SPINAL CORD; TRANSGENE; AGING; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SKIN; TRANSGENIC MOUSE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; MODELS, NEUROLOGICAL; OXIDATIVE STRESS; SKIN; SPINAL CORD; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953287885     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.04.005     Document Type: Article

References (38)

1. Kolde G., Bachus R., and Ludolph A.C. Skin involvement in amyotrophic lateral sclerosis. Lancet 347 (1996) 1226-1227
2. Furukawa T., and Toyokura Y. Letter: amyotrophic lateral sclerosis and bedsores. Lancet 1 (1976) 862
3. Ono S., Toyokura Y., Mannen T., and Ishibashi Y. Amyotrophic lateral sclerosis: histologic, histochemical, and ultrastructural abnormalities of skin. Neurology 36 (1986) 948-956
4. Ono S., and Yamauchi M. Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis. Acta Neurol Scand 86 (1992) 481-484
5. Ono S., and Yamauchi M. Amyotrophic lateral sclerosis: increased solubility of skin collagen. Neurology 42 (1992) 1535-1539
6. Beach R.L., Rao J.S., Festoff B.W., Reyes E.T., Yanagihara R., and Gajdusek D.C. Collagenase activity in skin fibroblasts of patients with amyotrophic lateral sclerosis. J Neurol Sci 72 (1986) 49-60
7. Fullmer H.M., Gibson W.A., Lazarus G., and Stam Jr. A.C. Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis. Lancet 1 (1966) 1007-1009
8. Vincenti M.P., and Brinckerhoff C.E. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?. J Cell Physiol 213 (2007) 355-364
9. Schoser B.G., and Blottner D. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle. Neuroreport 10 (1999) 2795-2797
10. Beuche W.Y.M., Mäder M., Maliszewska M., Felgenhauer K., and Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 11 (2000) 3419-3422
11. Demestre M., Parkin-Smith G., Petzold A., and Pullen A.H. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 159 (2005) 146-154
12. Lorenzl S., Narr S., Angele B., et al. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice. Exp Neurol 200 (2006) 166-171
13. Fang L., Huber-Abel F., Teuchert M., et al. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci (2009)
14. Bonnefont-Rousselot D., Lacomblez L., Jaudon M., et al. Blood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci 178 (2000) 57-62
15. Oteiza P.I., Uchitel O.D., Carrasquedo F., Dubrovski A.L., Roma J.C., and Fraga C.G. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 22 (1997) 535-539
16. Aguirre N., Beal M.F., Matson W.R., and Bogdanov M.B. Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis. Free Radic Res 39 (2005) 383-388
17. Weydt P., Yuen E.C., Ransom B.R., and Moller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 48 (2004) 179-182
18. Beckman K.B., Saljoughi S., Mashiyama S.T., and Ames B.N. A simpler, more robust method for the analysis of 8-oxoguanine in DNA. Free Radic Biol Med 29 (2000) 357-367
19. Lim G.P., Backstrom J.R., Cullen M.J., Miller C.A., Atkinson R.D., and Tokes Z.A. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 67 (1996) 251-259
20. Bornstein P.S.H. Structurally distinct collagen types. Ann Rev Biochem 49 (1980) 957-1003
21. Ono S., Imai T., Takahashi K., et al. Decreased type IV collagen of skin and serum in patients with amyotrophic lateral sclerosis. Neurology 51 (1998) 114-120
22. Ono S. The skin in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 191-199
23. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98 (1996) 2572-2579
24. 1/2 activation. J Biol Chem 276 (2001) 14264-14270
25. Saari H., Sorsa T., Lindy O., Suomalainen K., Halinen S., and Konttinen Y.T. Reactive oxygen species as regulators of human neutrophil and fibroblast interstitial collagenases. Int J Tissue React 14 (1992) 113-120
26. Zhang H.J., Zhao W., Venkataraman S., et al. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 277 (2002) 20919-20926
27. Shukla R., Rajani M., Barthwal M.K., Srivastava N., and Dikshit M. Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease. Int J Neurosci 113 (2003) 1043-1054
28. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256
29. Babu G.N., Kumar A., Chandra R., Puri S.K., Kalita J., and Misra U.K. Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem Res 33 (2008) 1145-1149
30. Cereda C., Baiocchi C., Bongioanni P., et al. TNF and sTNFR1/2 plasma levels in ALS patients. J Neuroimmunol 194 (2008) 123-131
31. Yan C., and Boyd D.D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211 (2007) 19-26
32. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253 (2003) 269-285
33. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 11 (2006) 479-491
34. Mancini A., and Di Battista J.A. Transcriptional regulation of matrix metalloprotease gene expression in health and disease. Front Biosci 11 (2006) 423-446
35. Agrawal S.M., Lau L., and Yong V.W. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 19 (2008) 42-51
36. McQuibban G.A., Gong J.H., Wong J.P., Wallace J.L., Clark-Lewis I., and Overall C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100 (2002) 1160-1167
37. Sellebjerg F., and Sorensen T.L. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 61 (2003) 347-355
38. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2 (2001) 502-511